Goldman Sachs Downgrades Thermo Fisher Scientific (TMO) to Neutral
Tweet
Share
E-mailGet Alerts TMO Hot Sheet
Price: $588.29 -1.28%
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Goldman Sachs downgraded Thermo Fisher Scientific (NYSE: TMO) from Buy to Neutral with a price target of $50 (down from $61).
The firm said TMO's business proved to be less resilient than expected as academic funding pressures negatively impacted results more than anticipated.
Goldman no longer believes defensive stock positioning is the best way to invest in Tools in this environment.
For an analyst ratings summary and ratings history on Thermo Fisher Scientific click here. For more ratings news on Thermo Fisher Scientific click here.
Shares of Thermo Fisher Scientific closed at $43.75 yesterday.
The firm said TMO's business proved to be less resilient than expected as academic funding pressures negatively impacted results more than anticipated.
Goldman no longer believes defensive stock positioning is the best way to invest in Tools in this environment.
For an analyst ratings summary and ratings history on Thermo Fisher Scientific click here. For more ratings news on Thermo Fisher Scientific click here.
Shares of Thermo Fisher Scientific closed at $43.75 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Thermo Fisher sells microbiology unit to Astorg for $1.075B
- Northcoast Downgrades Brinker Int'l (EAT) to Neutral
- Lake Street Downgrades SoundThinking (SSTI) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
